Week In Review: Sino Biopharm Subsidiary Enters $307 Million Agreement For Rights To NASH Candidate

Week In Review: Sino Biopharm Subsidiary Enters $307 Million Agreement For Rights To NASH Candidate By ChinaBio Today Goldman Sachs: Recession Fears Mostly Priced In By JR Research Citigroup: Compelling Risk/Reward Opportunity At 0.55x Book By IP Banking Research FEATURED Special Offer! 50% off Premium With ongoing inflation and rising rates, now's the time to ensure you own strong stocks. Go Premium and get access to expert analysis, lightning-fast news, and our 'Strong Buy' stock picks that are beating the market by more than 4-to-1. Find 'Strong Buy' stocks » Long Ideas Salesforce: Blazing Towards $50 Billion In Annual Revenue By Eric Sprague Snowflake: A Recovery Rally Is Waiting In The Wings By Gary Alexander ZIM Integrated: A Shipping Leader Trading At A Steep Discount By HIT Investments MPLX: An Energy Play For The Looming Recession Supported By A 10% Yield By JR Research The Devon Bull Case Looks Terrific Despite Macro Challenges By Leo Nelissen More Long Ideas » Quick Picks & Lists Enphase Energy: Continuing Nearby Capital-Gains-Based Energy Environmental Advancement By Peter F. Way, CFA Castor Maritime: Outstanding Financial Condition Despite Weaker Dry Bulk Market Conditions By Henrik Alex Soho House's Parent Is Undervalued - I'm Buying Membership Collective Group By Leo Imasuen Aveanna Healthcare - In Need Of Help By The Value Investor More Quick Picks & Lists » Download the Seeking Alpha App! Like Stock Ideas? Try our other newsletters as well. This email was sent to you because you signed up to receive Stock Ideas. If you do not want to receive Stock Ideas emails, click here to unsubscribe. Sent by Seeking Alpha, 234 5th Ave, 5 floor, New York, NY 10001